These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 12081250)
1. The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC). Amazigo UV; Brieger WR; Katabarwa M; Akogun O; Ntep M; Boatin B; N'Doyo J; Noma M; Sékétéli A Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S41-58. PubMed ID: 12081250 [TBL] [Abstract][Full Text] [Related]
2. APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control. Homeida M; Braide E; Elhassan E; Amazigo UV; Liese B; Benton B; Noma M; Etya'alé D; Dadzie KY; Kale OO; Sékétéli A Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S93-104. PubMed ID: 12081254 [TBL] [Abstract][Full Text] [Related]
3. The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Sékétéli A; Adeoye G; Eyamba A; Nnoruka E; Drameh P; Amazigo UV; Noma M; Agboton F; Aholou Y; Kale OO; Dadzie KY Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S15-28. PubMed ID: 12081247 [TBL] [Abstract][Full Text] [Related]
4. Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997-2000): an evaluation. Katabarwa MN; Habomugisha P; Richards FO Ann Trop Med Parasitol; 2002 Jan; 96(1):61-73. PubMed ID: 11998803 [TBL] [Abstract][Full Text] [Related]
5. Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Amazigo UV; Obono M; Dadzie KY; Remme J; Jiya J; Ndyomugyenyi R; Roungou JB; Noma M; Sékétéli A Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S75-92. PubMed ID: 12081253 [TBL] [Abstract][Full Text] [Related]
6. Gender issues in the community-directed treatment with ivermectin (CDTI) of the African Programme for Onchocerciasis Control (APOC). Clemmons L; Amazigo UV; Bissek AC; Noma M; Oyene U; Ekpo U; Msuya-Mpanju J; Katenga S; Sékétéli A Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S59-74. PubMed ID: 12081252 [TBL] [Abstract][Full Text] [Related]
7. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). Noma M; Nwoke BE; Nutall I; Tambala PA; Enyong P; Namsenmo A; Remme J; Amazigo UV; Kale OO; Sékétéli A Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S29-39. PubMed ID: 12081248 [TBL] [Abstract][Full Text] [Related]
8. Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda. Meredith SE; Cross C; Amazigo UV Health Res Policy Syst; 2012 May; 10():16. PubMed ID: 22574885 [TBL] [Abstract][Full Text] [Related]
9. Ivermectin and onchocerciasis: is it all solved? Hopkins AD Eye (Lond); 2005 Oct; 19(10):1057-66. PubMed ID: 16304585 [TBL] [Abstract][Full Text] [Related]
10. The African Programme for Onchocerciasis Control (APOC). Amazigo U Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():19-22. PubMed ID: 18718149 [TBL] [Abstract][Full Text] [Related]
11. The Mectizan Donation Program (MDP). Thylefors B Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154 [TBL] [Abstract][Full Text] [Related]
12. The World Bank. Bangoura O Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():31-3. PubMed ID: 18718152 [TBL] [Abstract][Full Text] [Related]
13. Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon. Duamor CT; Datchoua-Poutcheu FR; Chounna Ndongmo WP; Yoah AT; Njukang E; Kah E; Maingeh MS; Kengne-Ouaffo JA; Tayong DB; Enyong PA; Wanji S PLoS Negl Trop Dis; 2017 Nov; 11(11):e0005966. PubMed ID: 29155826 [TBL] [Abstract][Full Text] [Related]
14. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria. Brieger WR; Otusanya SA; Oke GA; Oshiname FO; Adeniyi JD Trop Med Int Health; 2002 Jan; 7(1):11-8. PubMed ID: 11851950 [TBL] [Abstract][Full Text] [Related]
15. A multi-centre study of community-directed ivermectin distributors' (CDDs') involvement in other healthcare and development programme activities in Cameroon, Togo, Sudan, Nigeria and Uganda. Sama MT; Homeida M; Ngang P; Liese BH; Amazigo U; Seketeli A Trop Doct; 2003 Oct; 33(4):237-41. PubMed ID: 14620432 [TBL] [Abstract][Full Text] [Related]
16. The selection and validation of indicators for monitoring progress towards self-sustainment in community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda. Katabarwa MN; Mutabazi D Ann Trop Med Parasitol; 1998 Dec; 92(8):859-68. PubMed ID: 10396346 [TBL] [Abstract][Full Text] [Related]
17. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results. Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645 [TBL] [Abstract][Full Text] [Related]
18. Community-directed health (CDH) workers enhance the performance and sustainability of CDH programmes: experience from ivermectin distribution in Uganda. Katabarwa MN; Richards FO Ann Trop Med Parasitol; 2001 Apr; 95(3):275-86. PubMed ID: 11339887 [TBL] [Abstract][Full Text] [Related]
19. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI). Mbanefo EC; Eneanya CI; Nwaorgu OC; Oguoma VM; Otiji MO; Ogolo BA Postgrad Med J; 2010 Oct; 86(1020):573-7. PubMed ID: 20971709 [TBL] [Abstract][Full Text] [Related]
20. A method to determine the coverage of ivermectin distribution in onchocerciasis-control programmes. Schwartz EC; Renk J; Hopkins AD; Huss R; Foster A Ann Trop Med Parasitol; 1998 Oct; 92(7):793-6. PubMed ID: 9924537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]